FDA may subject pacemaker programmers to premarket review

08/5/2011 | MassDevice.com (Boston)

The FDA has issued a proposed rule that would categorize pacemaker programmers, external tools designed to modify the electrical performance of pacemakers, as Class III devices and would subject them to premarket review. The rule follows an FDA guidance requiring pacemakers to undergo premarket evaluation.

View Full Article in:

MassDevice.com (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Program Manager II
Tufts Health Plan/Network Health
Medford, MA
Director, Medicare Advantage/Medicare Part D Focus
Avalere Health
Washington, DC